查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842253

美國動物再生醫學市場：市場規模、佔有率和趨勢分析（按產品、動物類型、應用和最終用途分類），細分市場預測（2025-2033 年）

U.S. Veterinary Regenerative Medicine Market Size, Share & Trends Analysis Report By Product, By Animal Type (Small Animals, Large Animals), By Application (Orthopedics, Trauma/Wound Care), By End-use And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

據估計，2024 年美國獸醫再生醫學市場價值為 1.0807 億美元，預計到 2033 年將達到 2.8168 億美元，2025 年至 2033 年的複合年成長率為 11.5%。

這個市場的主要驅動力是伴侶動物慢性疾病（如關節炎、骨關節炎和肌腱損傷）的日益普遍，這增加了對先進治療方案的需求。寵物飼養率的上升以及飼主願意在專業獸醫護理上投入更多資金，進一步推動了幹細胞療法和組織工程等再生醫學方法的應用。此外，獸醫生物技術公司不斷取得的技術進步和持續的投資，正在加速創新，並擴大再生醫學產品在國內的供應。

臨床研究透過為先進療法提供科學檢驗和監管認可，在推動美國獸醫再生醫學市場成長方面發揮著至關重要的作用。例如，根據美國食品藥物管理局（FDA）稱，美國，特別是紐約州，正在進行自體脂肪或骨髓間間質幹細胞治療犬類肌肉骨骼和神經系統疾病的臨床研究。這些研究不僅證明了再生療法治療關節炎和肌腱損傷等疾病的安全性和有效性，而且增強了獸醫和飼主的信心，並加速了其廣泛應用。此外，積極的臨床結果能夠促進監管機構的支持，加強產業合作，並吸引生技公司的投資，從而進一步強化創新管道。透過將前沿研究轉化為實際的獸醫應用，這些臨床試驗顯著促進了美國國內獸醫再生醫學市場的接受度、商業化和長期成長。

此外，獸醫研究院校和提供再生醫學服務的機構的存在，極大地促進了美國獸醫再生醫學市場的發展，它們充當了創新、培訓和服務提供的中心。例如，田納西大學農業研究所提供先進的服務，例如分離和擴增犬骨髓間質間質幹細胞，以及製備用於治療性注射的幹細胞。這些機構不僅支持臨床應用，也促進研發，進而推動再生技術在獸醫學領域的快速應用。透過提供專業服務和專業知識，它們提高了獸醫和飼主獲得再生醫學服務的便利性，增強了人們對先進療法的信任，並提高了大眾對再生療法的認知。此外，這些中心也作為與生物技術公司和監管機構合作的樞紐，最終促進再生醫學在美國獸醫學界的商業化和普及。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國動物再生醫學市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場
    • 子公司市場
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國動物再生醫學市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
  • 定價分析
  • 法律規範
  • 主要國家主要品種動物數量估計（2021-2024 年）

第4章：美國動物再生醫學市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 美國動物再生醫學市場：按產品分類的變化分析
  • 美國動物再生醫學市場規模及產品趨勢分析（2021-2033）
  • 幹細胞
  • 其他

第5章美國動物再生醫學市場：按動物類型分類的估算與趨勢分析

  • 細分儀表板
  • 美國動物再生醫學市場：按動物類型分類的變化分析
  • 美國動物再生醫學市場規模及趨勢分析（按動物類型分類）（2021-2033 年）
  • 小動物
  • 大型動物

第6章：美國動物再生醫學市場：按應用分類的估算與趨勢分析

  • 細分儀表板
  • 美國動物再生醫學市場：按應用領域分類的趨勢分析
  • 美國動物再生醫學市場規模與應用趨勢分析（2021-2033）
  • 整形外科
    • 創傷/創傷護理
  • 其他

第7章：美國動物再生醫學市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 美國動物再生醫學市場：依最終用途分類的變化分析
  • 美國動物再生醫學市場規模及趨勢分析（按最終用途分類）（2021-2033 年）
    • 動物診所和醫院
    • 獸醫研究所

第8章 競爭情勢

  • 市場參與企業分類
  • 企業市場分析/熱力圖分析
  • 公司簡介
    • Boehringer Ingelheim International GmbH
    • Zoetis
    • Dechra Pharmaceuticals PLC
    • Equine Amnio Solutions
    • VetStem, Inc
    • Hilltop Bio
    • Equi-Stem LLC
    • Ardent Equine
    • Pronoia Biotech
    • AniCell BioTech
  • 策略規劃
    • 企業合併（M&A）
    • 商業夥伴關係與合作
    • 產品/服務發布
    • 其他
  • 其他主要企業名單
Product Code: GVR-4-68040-731-4

Market Size & Trends:

The U.S. veterinary regenerative medicine market size was estimated at USD 108.07 million in 2024 and is projected to reach at USD 281.68 million by 2033, growing at a CAGR of 11.5% from 2025 to 2033. The market is primarily driven by the growing prevalence of chronic conditions such as arthritis, osteoarthritis, and tendon injuries in companion animals, which is increasing the demand for advanced therapeutic solutions. Rising pet ownership and the willingness of owners to spend more on specialized veterinary care have further fueled the adoption of regenerative approaches such as stem cell therapy and tissue engineering. In addition, continuous technological advancements and rising investments by veterinary biotechnology companies are accelerating innovation and expanding the availability of regenerative medicine products in the country.

Clinical studies play a pivotal role in driving the growth of the U.S. veterinary regenerative medicine market by providing scientific validation and regulatory credibility to advanced therapies. For instance, according to the FDA, clinical studies on autologous adipose- or bone marrow-derived mesenchymal stem cells for canine musculoskeletal and nervous system diseases are being conducted in the U.S., specifically in New York. Such studies not only demonstrate the safety and efficacy of regenerative therapies in treating conditions such as arthritis and tendon injuries but also build confidence among veterinarians and pet owners, thereby accelerating adoption. Moreover, positive clinical outcomes encourage regulatory support, foster industry collaborations, and attract investments from biotechnology companies, further strengthening innovation pipelines. By translating cutting-edge research into practical veterinary applications, these clinical trials significantly contribute to expanding the acceptance, commercialization, and long-term growth of the veterinary regenerative medicine market in the country.

Moreover, the presence of veterinary research colleges and institutes offering regenerative medicine services significantly drives the growth of the U.S. veterinary regenerative medicine market by serving as centers of innovation, training, and service delivery. For example, the University of Tennessee Institute of Agriculture provides advanced services such as isolation and expansion of bone marrow-derived mesenchymal stem cells in dogs, and preparation of these stem cells for therapeutic injections. Such institutions not only support clinical applications but also promote research and development, enabling faster translation of regenerative techniques into veterinary practice. By offering specialized services and expertise, they increase accessibility for veterinarians and pet owners, build trust in advanced treatments, and enhance awareness of regenerative therapies. Furthermore, these centers act as hubs for collaborations with biotechnology firms and regulatory bodies, ultimately expanding the commercialization and acceptance of regenerative medicine across the U.S. veterinary healthcare landscape.

U.S. Veterinary Regenerative Medicine Market Report Segmentation

This report forecasts revenue growth provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. veterinary regenerative medicine market report based on product, animal type, application, end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Stem Cells
    • Others
  • Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
    • Small Animals
    • Large Animals
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Orthopedics
    • Trauma/Wound Care
    • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
    • Veterinary Clinics & Hospitals
    • Veterinary Research Institutes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
    • 1.3.6. Data analysis model
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Veterinary Regenerative Medicine Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of orthopedic disorders in pets
      • 3.2.1.2. Rising pet expenditure and pet humanization
      • 3.2.1.3. Strategic initiatives by key players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of treatment.
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Veterinary Regenerative Medicine Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Legal landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Technological landscape
      • 3.3.2.6. Environmental landscape
  • 3.4. Pricing Analysis
  • 3.5. Regulatory Framework
  • 3.6. Estimated Animal Population by key Species, key countries, 2021 - 2024

Chapter 4. U.S. Veterinary Regenerative Medicine Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Veterinary Regenerative Medicine Market: Product Movement Analysis
  • 4.3. U.S. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Stem Cells
    • 4.4.1. Stem Cells Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 4.5. Others
    • 4.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 5. U.S. Veterinary Regenerative Medicine Market: Animal Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Veterinary Regenerative Medicine Market: Animal Type Movement Analysis
  • 5.3. U.S. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Animal Type, 2021 to 2033 (USD Million)
  • 5.4. Small Animals
    • 5.4.1. Small Animals Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 5.5. Large Animals
    • 5.5.1. Large Animals Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 6. U.S. Veterinary Regenerative Medicine Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Veterinary Regenerative Medicine Market: Application Movement Analysis
  • 6.3. U.S. Veterinary Regenerative Medicine Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Orthopedics
    • 6.4.1. Orthopedics Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
    • 6.4.2. Trauma/Wound Care
    • 6.4.3. Trauma/Wound Care Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. U.S. Veterinary Regenerative Medicine Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Veterinary Regenerative Medicine Market: By End Use Movement Analysis
  • 7.3. U.S. Veterinary Regenerative Medicine Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Clinics & Hospitals
      • 7.3.1.1. Veterinary Clinics & Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
    • 7.3.2. Veterinary Research Institute
      • 7.3.2.1. Veterinary Research Institute Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heat Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Boehringer Ingelheim International GmbH
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product/Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Zoetis
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product/Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Dechra Pharmaceuticals PLC
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product/Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Equine Amnio Solutions
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product/Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. VetStem, Inc
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product/Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Hilltop Bio
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product/Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Equi-Stem LLC
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product/Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Ardent Equine
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product/Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Pronoia Biotech
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product/Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. AniCell BioTech
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product/Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
  • 8.4. Strategy Mapping
    • 8.4.1. Mergers & Acquisitions
    • 8.4.2. Partnerships & Collaborations
    • 8.4.3. Product/Service launch
    • 8.4.4. Others
  • 8.5. List of other key players

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 U.S. Veterinary Regenerative Medicine Market, By Product, 2021 - 2033 (USD Million)
  • Table 3 U.S. Veterinary Regenerative Medicine Market, By Animal Type, 2021 - 2033 (USD Million)
  • Table 4 U.S. Veterinary Regenerative Medicine Market, By Application, 2021 - 2033 (USD Million)
  • Table 5 U.S. Veterinary Regenerative Medicine Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 Company Overview
  • Table 7 Product Benchmarking
  • Table 8 Financial Performance
  • Table 9 Strategic Initiatives

List of Figures

  • Fig. 1 Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modelling For Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 U.S. Veterinary Regenerative Medicine Market Revenue, 2021 - 2033 (USD Million)
  • Fig. 10 U.S. Veterinary Regenerative Medicine Market Snapshot
  • Fig. 11 U.S. Veterinary Regenerative Medicine Market Driver Impact
  • Fig. 12 U.S. Veterinary Regenerative Medicine Market Restraint Impact
  • Fig. 13 U.S. Veterinary Regenerative Medicine Product Key Takeaways (USD Million)
  • Fig. 14 U.S. Veterinary Regenerative Medicine Market: Product, Market Share 2024 & 2033
  • Fig. 15 Stem Cells Market, 2021 - 2033 (USD Million)
  • Fig. 16 Others Market, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Veterinary Regenerative Medicine Animal Type Key Takeaways (USD Million)
  • Fig. 18 U.S. Veterinary Regenerative Medicine Market: Animal Type, Market Share 2024 & 2033
  • Fig. 19 Small Animals Market, 2021 - 2033 (USD Million)
  • Fig. 20 Large Animals Market, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Veterinary Regenerative Medicine Application Key Takeaways (USD Million)
  • Fig. 22 U.S. Veterinary Regenerative Medicine Market: Application, Market Share 2024 & 2033
  • Fig. 23 Orthopedic Market, 2021 - 2033 (USD Million)
  • Fig. 24 Trauma/Wound Care Market, 2021 - 2033 (USD Million)
  • Fig. 25 Others Market, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Veterinary Regenerative Medicine Market By End Use: Key Takeaways
  • Fig. 27 U.S. Veterinary Regenerative Medicine Market By End Use, Market Share, 2024 & 2033
  • Fig. 28 Veterinary Clinics & Hospitals Market, 2021 - 2033 (USD Million)
  • Fig. 29 Veterinary Research Institutes Market, 2021 - 2033 (USD Million)
  • Fig. 30 Market Participant Categorization
  • Fig. 31 Market Share Of Key Market Players U.S. Veterinary Regenerative Medicine Market